drugset / Trial / NCT00259402
Oxaliplatin in Esophagus Cancer (Advanced) 1st Line
Non-randomizedParallel-groupOpen-labelTreatment
Summary
* To determine the activity and efficacy of the schema specified as dose regimen * To determine the safety and tolerability of the oxaliplatin-cisplatin and 5FU
Timeline
- Start
- 2000-02
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 55 mg/m2 | — |
| Subject | Oxaliplatin | Small molecule | 60 mg/m2 | — |
| Subject | fluorouracil | Small molecule | 600 mg/m2 | — |